National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 210 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 19 out of 21

Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID: 1763951 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-08-28
Onset:2021-09-13
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-10-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / 1 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Computerised tomogram, Facial paralysis, Fine motor skill dysfunction, Guillain-Barre syndrome, Lumbar puncture abnormal, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: protonix, vitamin D
Current Illness: none
Preexisting Conditions: none
Allergies: codiene
Diagnostic Lab Data: I had CT scans, MRI''s 9-13 thru 9 -18-2021. Diagnosed with Guillian-Barre after results of lumbar puncture by Dr. on 10/5/2021.
CDC Split Type:

Write-up: I received the vaccine on Aug 28th, 2021. I awoke on the morning on September 13th, 2021 with right side facial paralysis and was immediately taken to ER. I had a stroke work up and was admitted. On September 16th my loss of motor skills had spread to include my right leg.


VAERS ID: 1779370 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Male  
Location: Indiana  
Vaccinated:2021-06-17
Onset:2021-06-21
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Electromyogram abnormal, Guillain-Barre syndrome, Hypoaesthesia, Nerve conduction studies abnormal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: aspirin, atorvastatin, bisoprolol-HCTZ, glimepiride, insulin glargine, metformin, semaglutide
Current Illness:
Preexisting Conditions: diabetes, h/o stroke, hypertension, hyperlipidemia
Allergies: penicillin
Diagnostic Lab Data: See above.
CDC Split Type:

Write-up: Patient developed Guillain-Barre syndrome within a week of J&J vaccination. Progressive numbness and weakness. Initially attributed to diabetes but subsequently diagnosed as GBS w/ nerve conduction studies and EMG. Lumbar puncture is planned.


VAERS ID: 1794093 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Male  
Location: Nebraska  
Vaccinated:2021-08-04
Onset:2021-10-02
   Days after vaccination:59
Submitted: 0000-00-00
Entered: 2021-10-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Albumin CSF abnormal, Areflexia, Asthenia, Back pain, CSF cell count, Clostridium difficile infection, Clostridium test positive, Condition aggravated, Escherichia test positive, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Lumbosacral radiculopathy, Magnetic resonance imaging spinal abnormal, Mobility decreased, Muscular weakness, Plasmapheresis, Respiratory disorder, Scan with contrast abnormal, Stool analysis abnormal, Treponema test negative
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Cyclobenzaprine 10 mg 3 times daily as needed, Advair 2 50?50 MCG/dose 1 puff twice daily, ursodiol 300 mg 1 tab twice daily
Current Illness: Patient tested positive for c diff and E coli in stool on 9/30/2021
Preexisting Conditions: Gallbladder disease, chronic low back pain, COPD, HCV carrier, chronic diarrhea
Allergies: Throat swelling with shellfish
Diagnostic Lab Data: 10/5 MRI L spine WWO, lumbar puncture 10/6, CSF WNV, VDRL neg
CDC Split Type:

Write-up: Patient developed Guillain-Barre syndrome Initial exam with symmetric leg weakness and areflexia. MRI with lumbosacral nerve root enhancement. LP with albuminocytologic dissociation. Treated with IVIG and brief course of plasmapheresis. Currently improving but still hospitalized Patient is a 72-year-old with history of bladder cancer, COPD, low back pain with radiculopathy, and renal insufficiency admitted 10/4/2021. His presenting symptoms were combination of leg weakness and numbness. Symptoms started after 9/30 and 10/1 when he was putting together dog kennel. On 10/2 he began to have acute on chronic back pain and by 10/3 he had some weakness but able ambulate without difficulty. On the morning of 10/4 he was unable to get up from bed. He started develop some weakness in his hands. Symptoms are associated with some numbness of the legs which is progressed to his fingertips. Recent C. difficile infection for the last 3 days and has been on some vancomycin he stopped vancomycin thinking it was associated with his weakness. Patient thinks his symptoms have gotten even worse since yesterday. Now he is having more difficulties lifting his arms. He thinks his left arm is worse than his right arm. Legs seem to be about the same. Covid vaccine was around few months ago. No other recent vaccinations. Patient developed respiratory compromise and needed close monitoring though ultimately did not require intubation. Patient remains hospitalized and will need post-hospital rehab stay. Prognosis is indeterminate.


VAERS ID: 1794527 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-10-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20211028698

Write-up: GUILLAIN BARRE; This spontaneous report received from a consumer (offspring of the patient) via a company representative concerned a 77 year old male. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNWON) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, 2 weeks after vaccination, the patient was hospitalized for a week without a diagnosis. The patient was then transferred to another hospital in a plane ambulance, where the patient was diagnosed with Guillain Barre and was hospitalized (dates unspecified). It was reported that the patient made it even with critical breathing conditions, and that the patient did not have a lung collapse. The patient was hospitalized for 3 weeks and currently in rehabilitation since 4 weeks for therapies. It was reported that patient is expected to be get back home probably on the first week of November. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain Barre was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: 20211028698-covid-19 vaccine ad26.cov2.s- Guillain-Barre. This event(s) is labeled per regulatory authority and is therefore considered potentially related.


VAERS ID: 1795128 (history)  
Form: Version 2.0  
Age: 42.0  
Sex: Female  
Location: Connecticut  
Vaccinated:2021-04-05
Onset:2021-05-01
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-10-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 AR / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 70 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: lexapro losartan
Current Illness: n/a
Preexisting Conditions: thyroid high bp
Allergies: n/a
Diagnostic Lab Data:
CDC Split Type:

Write-up: guillain bare syndrome.


VAERS ID: 1804840 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-05-07
Onset:2021-05-22
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-10-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 203A21 / 1 LA / IM
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 203A21A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Bell's palsy, Gait inability, Guillain-Barre syndrome, Immunoglobulin therapy, Impaired work ability, Loss of personal independence in daily activities, Lumbar puncture abnormal, Mobility decreased, Pain, Protein total increased, Walking aid user
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dementia (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 22 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Aspirin 81 mg, lipitor 40mg, coreg 6.25 mg, colcrys 0.6 mg, lisinopril 5mg
Current Illness: none
Preexisting Conditions:
Allergies: none
Diagnostic Lab Data: spinal tap, found elevated protein so started IVIG on June 5th
CDC Split Type:

Write-up: started May 22nd with body aches & pains, then by May 26th it was bad enough to go the the ER, had Bell''s Palsy also start on that day. Was given some pain pills & went home. Back to providers office on June 1st and they sent to ER and was admitted to the hospital. Horrible pain everywhere even on the max amount of meds they would give. Went from a fully functioning man to needing 2 people to transfer and couldn''t write or cut food. After a few days the figures out it was Guillain Barre Syndrome and started IVIG for 5 days. still in extreme pain everyday. After 14 days was sent to the inpt rehab area to be able to try to learn to walk and get some hand function back. Still am unable to return to work because of hand function and cane usage. need a brace on one foot at all times.


VAERS ID: 1807384 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: Texas  
Vaccinated:0000-00-00
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-10-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808609 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death, Guillain-Barre syndrome, Intensive care, Mechanical ventilation
SMQs:, Peripheral neuropathy (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Respiratory failure (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-26
   Days after onset: 25
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210514945

Write-up: DEATH; INTENSIVE CARE; MECHANICAL VENTILATION; GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a health care professional via a Regulatory Authority the VAERS (Vaccine Adverse Event Reporting System) via literature. This report concerned a 57-year-old male of unknown race and ethnicity. The objective of this study was to assess reports of Guillain-Barre Syndrome (GBS) received in the Vaccine Adverse Event Reporting System (VAERS) following vaccination with covid-19 vaccine ad26.cov2.s. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2. s (suspension for injection, intramuscular, batch number: 1808609 and expiry: UNKNOWN) dose and vaccination site not reported, 1 total administered on 01-APR-2021 for prophylactic vaccination. Concomitant medications were not reported. On an unspecified date in APR-2021, within a week after vaccination, the patient experienced pain and weakness, the patient experienced Guillain-Barre syndrome and was hospitalized (date unspecified), including 6 days on a ventilator. The patient was in intensive care on mechanical ventilation. Reporter''s contact with the patient and doctor was unsuccessful but attempts were continuing. The patient was treated with a course of intravenous immunoglobulin. On 26-APR-2021, 25 days after vaccination the patient died from unknown cause of death. It was unknown if an autopsy was performed. Duration of hospitalization was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The author suggests a potential small but statistically significant safety concern for Guillain-Barre Syndrome following receipt of the covid-19 vaccine ad26.cov2.s. However, the findings are subject to the limitations of passive reporting systems and presumptive case definition, and they must be considered preliminary pending analysis of medical records to establish a definitive diagnosis. The patient died due to unknown cause of death on 26-APR-2021, and the outcome of guillain-barre syndrome, intensive care and mechanical ventilation was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Life Threatening). This case, from the same reporter is linked to 20211021308. This case, from same literature article is linked to 20211021340, 20211021338, 20211021361 and 20211021284. Additional information was received on 11-OCT-2021. It was determined that Manufacture Case number (20211021308) was a duplicate of this case. All relevant information (new event death and date of death added) this case will be submitted under a Manufacturer Case Number (20210514945).; Sender''s Comments: V1- This follow up updates- . All relevant information (new event death and date of death added) regarding duplicate Manufacture Case number (20211021308). 20210514945-COVID-19 VACCINE AD26.COV2.S-Guillain-Barre syndrome, This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). 20210514945-COVID-19 VACCINE AD26.COV2.S- Intensive care, mechanical ventilation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210514945-COVID-19 VACCINE AD26.COV2.S ?Death. Follow-up received regarding Clinical Details. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH


VAERS ID: 1807392 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Female  
Location: Florida  
Vaccinated:0000-00-00
Onset:2021-09-24
Submitted: 0000-00-00
Entered: 2021-10-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 212A21A / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, CSF protein, Chills, Computerised tomogram head, Guillain-Barre syndrome, Headache, Lumbar puncture, Magnetic resonance imaging, Magnetic resonance imaging head, Myalgia, Palpitations, Pyrexia, Stress, Tremor
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Alcohol use (once in every six months); Non-smoker; Palpitations; Seizure; Wolff-Parkinson-White syndrome (no medication)
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Comments: Patient did not have any drug abuse or illicit drug usage.
Allergies:
Diagnostic Lab Data: Test Date: 20210924; Test Name: Body temperature; Result Unstructured Data: 102 F; Test Date: 20210929; Test Name: MRI; Result Unstructured Data: not provided; Test Date: 20210929; Test Name: CSF protein; Result Unstructured Data: protein levels at 69; Test Date: 20210929; Test Name: MRI brain; Result Unstructured Data: not provided; Test Date: 20210929; Test Name: CT brain scan; Result Unstructured Data: ruled out stroke; Test Date: 20210929; Test Name: Lumbar puncture; Result Unstructured Data: Guillain-Barre syndrome
CDC Split Type: USJNJFOC20211033707

Write-up: GUILLAIN-BARRE SYNDROME; STRESS; ENTIRE BODY SHAKES; HEADACHE; PALPITATIONS; EXTREME CHILLS; DEEP MUSCLE PAIN; HIGH TEMPERATURE; This spontaneous report received from a patient concerned a 59 year old female. The patient''s height, and weight were not reported. The patient''s past medical history included: covid-19 infection(DEC-2020), and concurrent conditions included: wolff-parkinson-white syndrome, heart palpitations due to malformed heart blood vessel, alcohol user, non-smoker, and seizure and other pre-existing medical conditions included: Patient did not have any drug abuse or illicit drug usage. The patient experienced drug allergy when treated with diazepam for seizures. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A, and expiry: 21-DEC-2021) dose was not reported, 1 total, administered on 23-SEP-2021 13:00 at right arm for prophylactic vaccination. No concomitant medications were reported. On 24-SEP-2021 (midnight), patient experienced high temperature (about 102 F), extreme chills, deep muscle pain, tingling from neck to lower back to extremities. By 4:00 am, patient was paralyzed. During paralysis, she did not lose feeling, but she was unable to move. Patient stated that she was terrified and she refused to go to the hospital. Her husband did range of motion in all of her extremities. Within 5 hours, with husband''s assistance, patient was able to get on a walker and shuffle. The next day, the patient had shortness of breath and palpitations and she called the family doctor and made an appointment On 29-SEP-2021, patient was still on walker, and her vision was affected. Patient could not see clearly, and had headaches. The patient described it as a headache, not a migraine. The family doctor sent the patient to the emergency room was reported. The patient underwent through computerized tomogram scan of brain which ruled out stroke, cerebral spinal fluid with lumbar puncture 69 protein. A lumbar puncture diagnosed her with Guillain-Barre syndrome and on 29-SEP-2021, she was admitted to the hospital to the neuro floor. A magnetic resonance imaging of the brain and the entire spinal column was performed. Treatment with Intravenous immunoglobulins of 5 infusions. On 05-OCT-2021 the patient was discharged after 7 days was reported. At the time of reporting on 18-OCT-2021, the patient was able to walk 0.25 miles, but then got tired. The patient was still having tingling on the left side, in particular left foot and left hand. The patient was still getting a headache that would get up at night, but medication was not needed. Her vision was back. It was reported that the patient does not understand, if she got stressed, her entire body shakes for 15 mins. She could not get upset. The patient felt embarrassed of losing control of her body was reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from palpitations on 01-OCT-2021, and extreme chills, and high temperature on 24-SEP-2021, was recovering from headache, and guillain-barre syndrome, had not recovered from deep muscle pain, and the outcome of stress and entire body shakes was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: 20211033707-covid-19 vaccine ad26.cov2.s-Guillain-Barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.


VAERS ID: 1817188 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2021-04-07
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20211043144

Write-up: GUILLAIN BARRE SYNDROME; This spontaneous report received from a patient via a company representative from social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 07-APR-2021, the patient reported slammed with acute pain, unable to walk and then bedridden. As per the patient, it was guillain barre syndrome, incurable and sometimes deadly. No one told about that to patient. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the guillain barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: Please provide: 1. Results/dates of viral and bacterial PCR panel and serology (e.g. IgG antibodies to: GQ1b, GM1, glycolipids; antiganglioside antibodies; IgG/IgM, PCR for: common cold, flu, Epstein-Barr, Herpes simplex, Herpes Zoster, adenovirus, coxsackievirus, cytomegalovirus, respiratory syncytial virus infection, Campylobacter jejuni, Borrelia burgdorferi), COVID-19 test (PCR or antibody/ELISA) 2. Symptoms of: common cold, flu-like symptoms, fever, Epstein-Barr, Herpes simplex, Herpes Zoster, adenovirus infection, cytomegalovirus, respiratory syncytial virus infection, coxsackievirus, diarrhea/bloody diarrhea, Lyme disease, COVID-19, other infectious illnesses, recent visit to forest or travel? 3. Vaccinations and hospitalizations 6 weeks prior to onset? Prior GBS event? 4. Describe the clinical progression of symptoms, including time to nadir of weakness, plateau and recovery/worsening. 5. Neurology report. 6. Electromyography, Spinal MRI, CSF analysis (protein, WBC) results. V0:


VAERS ID: 1818893 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2021-04-12
Onset:2021-05-18
   Days after vaccination:36
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808609 / 1 AR / SYR

Administered by: Private       Purchased by: ?
Symptoms: Alcohol test negative, Computerised tomogram head, Disability, Drug screen negative, Dysstasia, Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Magnetic resonance imaging head, Weight bearing difficulty, X-ray
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 60 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: unknown
Current Illness: none
Preexisting Conditions:
Allergies: none
Diagnostic Lab Data: MRI Brain, CT Brain, Lumbar puncture, Xray, routine labs
CDC Split Type:

Write-up: Symptoms started 1 week prior to hospitalization. He was admitted to the Hospital May 23 or 24th with suspected alcohol withdrawl symptoms but upon routine testing all results came back negative for alcohol or drugs. From there the hospitalist ordered numereous testings of the brain. MRI could not rule out a stoke but could not verify. treated him for GBS since symptoms started 4 weeks after the covid shot was given. He remained in the hospital for 3 months and was moved to a nursing home. He is still unable to stand or put much weight on his legs. He has been handicapped since May.


Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=19&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166